GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Hspa5 | increases expression | EXP | | 6480464 | CTD | Rifampin results in increased expression of HSPA5 protein | PMID:24638036 | Hspa5 | multiple interactions | EXP | | 6480464 | CTD | ATF4 mutant form inhibits the reaction [Rifampin results in increased expression of HSPA5 protein] | PMID:24638036 | Hspa5 | increases expression | ISO | HSPA5 (Homo sapiens) | 6480464 | CTD | Rifampin results in increased expression of HSPA5 mRNA; Rifampin results in increased expression of HSPA5 protein | PMID:27470132 PMID:32535746 | Hspa5 | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | CTD | [Rifampin co-treated with Cobicistat] results in increased expression of HSPA5 mRNA | PMID:33629115 | Hspa5 | multiple interactions | ISO | HSPA5 (Homo sapiens) | 6480464 | CTD | 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 protein] | PMID:27470132 | |
Go Back to source page | Continue to Ontology report |